Nomura On Lupin
Maintain Buy, TP Cut To Rs 913 From Rs 1017
US Has Been Disappointing; Low Expectations Make Risk-reward Favourable
Expect Resolution Of Gavis & Indore/Goa Site In FY21
Mkt Not Factoring In Any Meaningful Upside From Innovation, Biosimilar